# PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)

> **NCT07106970** · NA · RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 640 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Linear ablation
- **PROCEDURE:** PVI alone

## Key facts

- **NCT ID:** NCT07106970
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-28
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 640 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07106970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07106970, "PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07106970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*